Liver cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The patient is at least 18 years old; 2. Pathologically diagnosed as hepatocellular carcinoma by liver biopsy, having received anti-hepatitis B virus treatment for at least 6 months before immunotherapy and achieved viral suppression, or initiating anti-hepatitis B virus treatment at the time of immunotherapy; 3. Child-Pugh classification is grade A or grade B (7); 4. ECOG PS score: 0–1 point; 5. There is at least one measurable target lesion according to the mRECIST standard.
Exclusion criteria
Exclusion criteria: 1. There are any serious comorbidities of other vital organs; 2. The patient has a history or current concurrent presence of other malignant tumors; 3. Those with incomplete medical records.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of HBV Reactivation;Progression-Free Survival; | — |
Countries
China
Contacts
The Fifth Medical Center of Chinese PLA General Hospital